Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
Press release

Publication of circular and notice of general meeting

Oxford, U.K. – 18 May 2022: Sensyne Health plc (LSE:SENS) announces that further to the announcement made on 19 April 2022 regarding the execution of an amendment and restatement to the note purchase agreement with existing and new secured lenders (the “Strategic Financing”), a circular (the “Circular”) has been published on the Company’s website, www.sensynehealth.com, and will shortly be posted to Shareholders.

May 18, 2022

The Circular contains the notice convening the General Meeting to be held at 11.00 a.m. (UK time) on 6 June 2022 to consider certain Resolutions in connection with the Strategic Financing (including the Rule 9 Waiver Resolution). 

This Announcement also constitutes the notification of the Company's intention to cancel the admission of its Ordinary Shares from trading on AIM.

Unless otherwise indicated, capitalised terms in this Announcement have the meaning given to them in the definitions section included in Appendix II.

The Circular contains, amongst other things, a letter from the Chairman of Sensyne (which is reproduced in full below), details of the Strategic Financing, the effects of the AIM Delisting and the Re-registration, additional information on the Concert Party, a notice of General Meeting, an indicative timetable of principal events (which is attached as Appendix I to this Announcement) and action to be taken by Shareholders. Shareholders should read the Circular carefully and in its entirety before making a decision with respect to the Resolutions.

Read more here

Press release

Publication of circular and notice of general meeting

May 18, 2022
Oxford, U.K. – 18 May 2022: Sensyne Health plc (LSE:SENS) announces that further to the announcement made on 19 April 2022 regarding the execution of an amendment and restatement to the note purchase agreement with existing and new secured lenders (the “Strategic Financing”), a circular (the “Circular”) has been published on the Company’s website, www.sensynehealth.com, and will shortly be posted to Shareholders.

The Circular contains the notice convening the General Meeting to be held at 11.00 a.m. (UK time) on 6 June 2022 to consider certain Resolutions in connection with the Strategic Financing (including the Rule 9 Waiver Resolution). 

This Announcement also constitutes the notification of the Company's intention to cancel the admission of its Ordinary Shares from trading on AIM.

Unless otherwise indicated, capitalised terms in this Announcement have the meaning given to them in the definitions section included in Appendix II.

The Circular contains, amongst other things, a letter from the Chairman of Sensyne (which is reproduced in full below), details of the Strategic Financing, the effects of the AIM Delisting and the Re-registration, additional information on the Concert Party, a notice of General Meeting, an indicative timetable of principal events (which is attached as Appendix I to this Announcement) and action to be taken by Shareholders. Shareholders should read the Circular carefully and in its entirety before making a decision with respect to the Resolutions.

Read more here

Press release

Publication of circular and notice of general meeting

Publication of circular and notice of general meeting

May 18, 2022
Oxford, U.K. – 18 May 2022: Sensyne Health plc (LSE:SENS) announces that further to the announcement made on 19 April 2022 regarding the execution of an amendment and restatement to the note purchase agreement with existing and new secured lenders (the “Strategic Financing”), a circular (the “Circular”) has been published on the Company’s website, www.sensynehealth.com, and will shortly be posted to Shareholders.

The Circular contains the notice convening the General Meeting to be held at 11.00 a.m. (UK time) on 6 June 2022 to consider certain Resolutions in connection with the Strategic Financing (including the Rule 9 Waiver Resolution). 

This Announcement also constitutes the notification of the Company's intention to cancel the admission of its Ordinary Shares from trading on AIM.

Unless otherwise indicated, capitalised terms in this Announcement have the meaning given to them in the definitions section included in Appendix II.

The Circular contains, amongst other things, a letter from the Chairman of Sensyne (which is reproduced in full below), details of the Strategic Financing, the effects of the AIM Delisting and the Re-registration, additional information on the Concert Party, a notice of General Meeting, an indicative timetable of principal events (which is attached as Appendix I to this Announcement) and action to be taken by Shareholders. Shareholders should read the Circular carefully and in its entirety before making a decision with respect to the Resolutions.

Read more here

Press release

Publication of circular and notice of general meeting

Oxford, U.K. – 18 May 2022: Sensyne Health plc (LSE:SENS) announces that further to the announcement made on 19 April 2022 regarding the execution of an amendment and restatement to the note purchase agreement with existing and new secured lenders (the “Strategic Financing”), a circular (the “Circular”) has been published on the Company’s website, www.sensynehealth.com, and will shortly be posted to Shareholders.

The Circular contains the notice convening the General Meeting to be held at 11.00 a.m. (UK time) on 6 June 2022 to consider certain Resolutions in connection with the Strategic Financing (including the Rule 9 Waiver Resolution). 

This Announcement also constitutes the notification of the Company's intention to cancel the admission of its Ordinary Shares from trading on AIM.

Unless otherwise indicated, capitalised terms in this Announcement have the meaning given to them in the definitions section included in Appendix II.

The Circular contains, amongst other things, a letter from the Chairman of Sensyne (which is reproduced in full below), details of the Strategic Financing, the effects of the AIM Delisting and the Re-registration, additional information on the Concert Party, a notice of General Meeting, an indicative timetable of principal events (which is attached as Appendix I to this Announcement) and action to be taken by Shareholders. Shareholders should read the Circular carefully and in its entirety before making a decision with respect to the Resolutions.

Read more here

Arrange to meet us
Press release

Publication of circular and notice of general meeting

May 18, 2022
Oxford, U.K. – 18 May 2022: Sensyne Health plc (LSE:SENS) announces that further to the announcement made on 19 April 2022 regarding the execution of an amendment and restatement to the note purchase agreement with existing and new secured lenders (the “Strategic Financing”), a circular (the “Circular”) has been published on the Company’s website, www.sensynehealth.com, and will shortly be posted to Shareholders.

The Circular contains the notice convening the General Meeting to be held at 11.00 a.m. (UK time) on 6 June 2022 to consider certain Resolutions in connection with the Strategic Financing (including the Rule 9 Waiver Resolution). 

This Announcement also constitutes the notification of the Company's intention to cancel the admission of its Ordinary Shares from trading on AIM.

Unless otherwise indicated, capitalised terms in this Announcement have the meaning given to them in the definitions section included in Appendix II.

The Circular contains, amongst other things, a letter from the Chairman of Sensyne (which is reproduced in full below), details of the Strategic Financing, the effects of the AIM Delisting and the Re-registration, additional information on the Concert Party, a notice of General Meeting, an indicative timetable of principal events (which is attached as Appendix I to this Announcement) and action to be taken by Shareholders. Shareholders should read the Circular carefully and in its entirety before making a decision with respect to the Resolutions.

Read more here